Simultaneous quantification of the 22-kDa isoforms of human growth hormone 1 and 2 in human plasma by multiplexed immunocapture and LC-MS/MS.

Biomarker Human growth hormone 1 Immunocapture Isoform Liquid chromatography-tandem mass spectrometry (LC-MS/MS) human growth hormone 2

Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
22 Dec 2023
Historique:
received: 08 11 2023
revised: 30 11 2023
accepted: 19 12 2023
medline: 25 12 2023
pubmed: 25 12 2023
entrez: 24 12 2023
Statut: aheadofprint

Résumé

An LC-MS/MS method is presented for the simultaneous quantification of two structurally closely related protein biomarker isoforms, the 22-kDa isoforms of human growth hormone 1 and human growth hormone 2, in human plasma. It is based on multiplexed immunocapture using two monoclonal antibodies immobilized on magnetic beads, tryptic digestion and quantification of two specific signature peptides plus an additional peptide for estimation of total growth hormone related concentrations. A full validation according to international guidelines was performed across the clinically relevant concentration ranges of 0.5 to 50 ng/mL for growth hormone 1, and 2 to 50 ng/mL for growth hormone 2 and demonstrated satisfactory method performance in terms of accuracy, precision, stability and absence of interference. The method's applicability for routine analysis and its ability to effectively distinguish between GH1 and GH2 was demonstrated by the analysis of plasma samples from pregnant individuals to study the changes in growth hormone levels during pregnancy.

Identifiants

pubmed: 38142804
pii: S0009-8981(23)00538-7
doi: 10.1016/j.cca.2023.117736
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117736

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Bas Sleumer (B)

ICON Bioanalytical Laboratories, Amerikaweg 18, 9407 TK, Assen, The Netherlands; Department of Analytical Biochemistry University of Groningen, A. Deusinglaan 1, 9700 AV Groningen, The Netherlands; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, EA61, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

Martijn van Faassen (M)

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, EA61, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

Michel J Vos (MJ)

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, EA61, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

Gijs den Besten (G)

Department of Clinical Chemistry, Isala, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.

Ido P Kema (IP)

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, EA61, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

Nico C van de Merbel (NC)

ICON Bioanalytical Laboratories, Amerikaweg 18, 9407 TK, Assen, The Netherlands; Department of Analytical Biochemistry University of Groningen, A. Deusinglaan 1, 9700 AV Groningen, The Netherlands. Electronic address: n.c.van.de.merbel@rug.nl.

Classifications MeSH